KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Cash from Financing Activities (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Cash from Financing Activities readings, the most recent being $8.1 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 4110.84% to $8.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.8 million, a 1122.14% increase, with the full-year FY2025 number at $17.8 million, up 1122.14% from a year prior.
  • Cash from Financing Activities hit $8.1 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $9.9 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $1.5 billion in Q3 2021 to a low of -$11.0 million in Q4 2021.
  • Median Cash from Financing Activities over the past 5 years was -$412000.0 (2021), compared with a mean of $82.1 million.
  • Biggest five-year swings in Cash from Financing Activities: crashed 5837.1% in 2021 and later skyrocketed 4110.84% in 2025.
  • Ginkgo Bioworks Holdings' Cash from Financing Activities stood at -$11.0 million in 2021, then soared by 985.29% to $97.8 million in 2022, then plummeted by 100.65% to -$632000.0 in 2023, then soared by 67.88% to -$203000.0 in 2024, then skyrocketed by 4110.84% to $8.1 million in 2025.
  • The last three reported values for Cash from Financing Activities were $8.1 million (Q4 2025), $9.9 million (Q3 2025), and -$98000.0 (Q2 2025) per Business Quant data.